Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News
Nature Biotechnology 26, 846–847 (1 August 2008) | doi:10.1038/nbt0808-846c
UK strong arms industry over drug pricing
Abstract
The UK pharmaceutical and biotech industries are claiming success in their negotiations with government over drug prices, although the deal is less than propitious. An immediate price freeze is to be followed by an across-the-board 5% price cut starting in January 2009.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
